BioSpace News Archive

Drug Development

J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery

Johnson & Johnson’s AI investments include a research facility in San Francisco and a data science workforce of approximately 6,000 employees.

December 4, 2023
·
2 min read
·
Tristan Manalac
FDA

Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor

Lilly’s Jaypirca (pirtobrutinib) can now be used to treat chronic lymphocytic leukemia or small lymphocytic leukemia that had progressed from at least two prior lines of therapy, in addition to its previously-approved indications.

December 4, 2023
·
2 min read
·
Tristan Manalac
Policy

EMA Requests More Data from GLP-1 Drugmakers in Suicidal Ideation, Self-Harm Probe

The European Medicines Agency is seeking additional information from the makers of GLP-1 drugs as part of its ongoing review of the potential risk of suicide and self-harm thoughts associated with the class.

December 4, 2023
·
2 min read
·
Tyler Patchen
Deals

Roche Jumps into Lucrative Weight-Loss Space with $2.7B Carmot Buy

The acquisition will give Roche access to Carmot’s clinical portfolio of three GLP-1 receptor agonists, placing it squarely in the middle of the competition to treat overweight and obesity.

December 4, 2023
·
2 min read
·
Tristan Manalac
Business

AstraZeneca to Spend $247M in Collaboration with AI Discovery Outfit Absci

In the latest example of big pharma entering AI collaborations or using AI-based tools, AstraZeneca’s deal with Absci will aim to produce an oncology candidate.

December 4, 2023
·
2 min read
·
Tyler Patchen
Amgen-Backed Seismic Secures $121M in Series B Funding

Mass.-based Seismic Therapeutic secured a new investor in Bessemer Venture Partners and $121 million in its Series B round as it looks to push its two lead candidates into the clinic.

December 4, 2023
·
2 min read
·
Tyler Patchen
Drug Development

EyePoint Pharma Stock Surges on Phase II Wet AMD-Therapy Results

EyePoint Pharmaceuticals’ treatment for wet age-related macular degeneration showed comparable results to Regeneron’s Eylea with a less frequent dosing regimen.

December 4, 2023
·
2 min read
·
Connor Lynch
Opinion: To Alleviate Supply Chain Shortages, Companies Should Share Data

The pharma industry serves patients best when data is shared, and privacy concerns can stand in the way of resolving critical supply chain issues.

December 4, 2023
·
4 min read
·
Nick Armstrong
Business

Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics

Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, announced it has entered into a collaboration agreement with Lycia Therapeutics, a leader in extracellular protein degradation.

December 4, 2023
·
2 min read
Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology

Supercell Biotechnology Corporation commemorates the first anniversary of rebranding from previously-called SinoCell Technologies, due to the company’s capital increase by RMT Holding Group.

December 4, 2023
·
3 min read